C4 Therapeutics Inc. (NASDAQ:CCCC) concluded the trading at $27.54 on Friday, January 14 with a rise of 1.85% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $27.04 with its price kept floating in the range of $25.61 and $27.73 on the day. Considering stock’s 52-week price range provides that CCCC hit a high price of $51.21 and saw its price falling to a low level of $26.39 during that period. Over a period of past 1-month, stock came subtracting -9.70% in its value.
With its current market valuation of $1.44 billion, C4 Therapeutics Inc. is set to declare its quarterly results on Mar 09, 2022 – Mar 14, 2022. Analysts are in estimates of -$0.59 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$2.06 for 2021 with estimates of that growing to -$2.38 in next year. These estimates are suggesting current year growth of 64.70% for EPS and -15.50% growth next year.
Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $7.24 million. They suggested that in the process company could generate revenue of as low as $4.29 million which could climb up to $9.29 million to hit a high. The average estimate is representing a decrease of -12.40% in sales growth from that of posted by the company in the same quarter of last year. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of $32.94 million in 2021, which will be -0.80% less from revenue generated by the company last year.
In last 7 days, analysts came adjusting their opinions about stock’s EPS with no upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review CCCC stock’s current outlook then short term indicators are assigning it an average of 100% Sell, while medium term indicators are categorizing the stock at an average of 100% Sell. Long term indicators are suggesting an average of 50% Sell for it.
Digging deeper we become aware of the PEG ratio of the CCCC stock which is currently positioned at 0. It further provides that stock’s current price level is -11.62% away from its 20-day simple moving average and is -22.78% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 36.48 while volatility remained at 9.12% over the past week which changes to 7.32% when measuring it over the past month. Average true range or ATR is currently at 2.31.
Having a second look at C4 Therapeutics Inc. (NASDAQ:CCCC) provides that stock’s average daily trading volume for 3 months was 300.06K. Number of outstanding shares of the stock stood at 48.49 million.
The percentage of outstanding shares held by the insiders is 0.30% while it is 71.90% for the institutional holders. Subtraction of -14.47% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.